ACTRN12622000933752已完成1 期
A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled,Single and Multiple Ascending Intravenous Dose Study toAssess the Safety, Tolerability, Pharmacokinetics of VGL101 in HealthyAdults
Vigil Neuroscience, Inc0 个研究点目标入组 60 人开始时间: 2022年6月30日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •Males and females between 18 to 55 years of age, inclusive, at the Screening Visit.
排除标准
- •Participant has any concurrent disease or condition that, in the opinion of the PI, would
- •make the participant unsuitable for participation in the clinical study.
研究者
相似试验
已完成
不适用
A First in Human, Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Total Daily Dose Study to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Intravenous Infusion of OMN6 in Healthy SubjectsNL-OMON51720Omnix Medical104
已完成
1 期
A study to investigate the safety and concentration in the blood and urine of different dose strengths of OCT461201 in healthy volunteersISRCTN39003837Oxford Cannabinoids Technologies Ltd.32
已完成
1 期
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses of EMP-01 in Healthy Adult VolunteersPost-traumatic stress disorder (PTSD)Mental Health - Other mental health disordersACTRN12622001335785EmpathBio Australia Pty. Ltd.32
已完成
不适用
A First-in-Human, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics of WK0202 Capsule in Healthy Adult Male and Female SubjectsKCT0004830Seoul National University Hospital120
招募中
1 期
A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of a ginger tincture extract in healthy volunteers.Rheumatoid ArthritisACTRN12624000125527Evithé Biotechnology Ltd.40